| Filed On | Filing |
|---|---|
| 13 Nov 2026 | 13F-HR |
| 12 Nov 2026 | 144 |
| 04 Nov 2026 | 10-Q |
| 03 Nov 2026 |
Form 4: Diaz Paul J, Director
Granted 613.073 Phantom Stock ($91.7K) |
| 03 Nov 2026 |
Form 3: Diaz Paul J, Director
Holds 200 shares of Common Stock |
| 02 Nov 2026 | 144 |
| 29 Oct 2026 |
8-K: Results of Operations and Financial Condition
Sum of quarterly amounts may not equal year-to-date amounts due to rounding. |
| 22 Oct 2026 |
Form 3/A: Maraldo David R., EVP & Pres. MMD
Holds 2,870.7727 shares of Common Stock - 401(k) Plan |
| 15 Oct 2026 | 25-NSE |
| 13 Oct 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
____________________________________________________________________________ |
| 01 Oct 2026 |
Form 4: Seidman Christine E, Director
Granted 55.9149 Phantom Stock ($8.12K) |
| 01 Oct 2026 |
Form 4: Karsanbhai Surendralal Lanca, Director
Granted 111.8299 Phantom Stock ($16.3K) |
| 01 Oct 2026 |
Form 4: Coe Mary Ellen, Director
Granted 206.4552 Phantom Stock ($30K) |
| 01 Sep 2026 |
Form 3: Gupta Gaurav K, EVP, CIDO
Holds 750 shares of Common Stock |
| 13 Aug 2026 |
Form 4: Guindo Chirfi, EVP, Access, Policy & Comms
Sold 10,000 shares ($1.35M) |
| 13 Aug 2026 | 144 |
| 13 Aug 2026 |
Form 4: Zachary Jennifer, EVP, General Counsel
Received 54,927 shares by exercise or conversion ($6.03M) · Sold 80,315 shares ($10.7M) |
| 12 Aug 2026 | 144 |
| 12 Aug 2026 | 144 |
| 12 Aug 2026 |
Form 4: DeLuca Richard R., EVP&Pres, Merck Animal Heallth
Sold 20,784 shares ($2.71M) · Sold 12,837 shares ($1.69M) · Sold 11,699 shares ($1.54M) |
Loading...